The optimal morning:evening ratio in total dose of twice-daily biphasic insulin analogue in poorly controlled Type 2 diabetes: a 24-week multi-centre prospective, randomized controlled, open-labelled clinical study (Q45391402)

From Wikidata

Jump to navigation Jump to search

scientific article published on 21 October 2013

Language	Label	Description	Also known as
English	The optimal morning:evening ratio in total dose of twice-daily biphasic insulin analogue in poorly controlled Type 2 diabetes: a 24-week multi-centre prospective, randomized controlled, open-labelled clinical study	scientific article published on 21 October 2013

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

The optimal morning:evening ratio in total dose of twice-daily biphasic insulin analogue in poorly controlled Type 2 diabetes: a 24-week multi-centre prospective, randomized controlled, open-labelled clinical study (English)

1 reference

Europe PubMed Central

14 December 2017

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24118113%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24118113%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

J-Y Park

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24118113%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

J H Cho

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24118113%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

K-H Yoon

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24118113%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

H K Yang

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24118113%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Y-H Lee

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24118113%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

B-W Lee

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24118113%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

21 October 2013

1 reference

Europe PubMed Central

14 December 2017

Diabetic Medicine

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24118113%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

31

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24118113%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

68-75

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24118113%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24118113%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Type 2 diabetes: principles of pathogenesis and therapy

1 reference

https://api.crossref.org/works/10.1111%2FDME.12322

21 January 2018

Why, when and how to initiate insulin therapy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDME.12322

21 January 2018

Glycemic Effects of Once-a-Day Rapid-Acting Insulin Analogue Addition on a Basal Insulin Analogue in Korean Subjects with Poorly Controlled Type 2 Diabetes Mellitus.

1 reference

https://api.crossref.org/works/10.1111%2FDME.12322

21 January 2018

Efficacy of biphasic insulin aspart in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDME.12322

21 January 2018

Practical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analogues

1 reference

https://api.crossref.org/works/10.1111%2FDME.12322

21 January 2018

Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).

1 reference

https://api.crossref.org/works/10.1111%2FDME.12322

21 January 2018

Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).

1 reference

https://api.crossref.org/works/10.1111%2FDME.12322

21 January 2018

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

1 reference

https://api.crossref.org/works/10.1111%2FDME.12322

21 January 2018

Higher morning to evening ratio in total dose of twice-daily biphasic insulin analog might be effective in achieving glucose control in patients with poorly controlled type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FDME.12322

21 January 2018

Efficacy and safety of biphasic insulin aspart 30/70 in type 2 diabetes suboptimally controlled on oral antidiabetic therapy in Korea: a multicenter, open-label, single-arm study

1 reference

https://api.crossref.org/works/10.1111%2FDME.12322

21 January 2018

Predictive characteristics of patients achieving glycaemic control with insulin after sulfonylurea failure.

1 reference

https://api.crossref.org/works/10.1111%2FDME.12322

21 January 2018

Safety and efficacy of modern insulin analogues

1 reference

https://api.crossref.org/works/10.1111%2FDME.12322

21 January 2018

Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDME.12322

21 January 2018

Practical guidance on intensification of insulin therapy with BIAsp 30: a consensus statement

1 reference

https://api.crossref.org/works/10.1111%2FDME.12322

21 January 2018

Insulin secretory dysfunction and insulin resistance in the pathogenesis of korean type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FDME.12322

21 January 2018

Dysfunctional pancreatic beta-cells of critical stress play a more prominent role in the development of stress diabetes in critically burned Korean subjects.

1 reference

https://api.crossref.org/works/10.1111%2FDME.12322

21 January 2018

Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDME.12322

21 January 2018

Diabetes in Asia: epidemiology, risk factors, and pathophysiology

1 reference

https://api.crossref.org/works/10.1111%2FDME.12322

21 January 2018

Identifiers

10.1111/DME.12322

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24118113%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

release_m4gqmfkatbeenglfhp6wbokhku

1 reference

https://api.fatcat.wiki/v0/release/m4gqmfkatbeenglfhp6wbokhku

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24118113%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45391402&oldid=2076356076"